Abstract. The compounds that bind steroid hormone receptors including estrogen receptors (ERs), progesterone receptor (PR) or androgen receptor (AR), and induce or modulate a steroid hormone receptor-mediated response could be defined as endocrine disruptors (EDs). Currently, there are no standard methods to determine whether a chemical is an endocrine disruptor or not. Most results of in vitro and in vivo data are derived from assays that measure estrogenic activity, thus fewer data are available from assays that measure androgenic and progestogenic activities. In this review, we introduce a novel in vivo model to detect EDs using immature rats in the induction of Calbindin-D9k (CaBP-9k) mRNA and protein by estrogenic compounds. In addition, we summarize other biomarkers and screening methods for EDs in mammals to describe the usefulness of indicated biomarkers, although mammalian models are very few based on experimental findings.
structures of the estrogenic phenol compounds, octylphenol, nonylphenol and bisphenol are shown in Fig. 1 together with that of 17β-estradiol (E2). Some of these phenols are breakdown products of surfactants, found in soaps and detergents. In addition, heavy metals, plastics, cosmetics, textiles, paints, and lubricants have been implicated as EDs. Sewage treatment effluent may contain a variety of natural and man made endocrine disruptors as well, including natural hormones from animal and human waste.
Currently, there are no standard methods to determine whether a chemical is an endocrine disruptor or not. As many endocrine disruptors are thought to affect sex hormone functions, and therefore reproduction, the findings of multigeneration animal studies may provide evidence of the potential for endocrine disruption. In vitro methods for the detection of estrogenic compounds have been developed by several groups, i.e., in vitro ER binding assay, MCF-7 human breast cancer cell proliferation assay and yeast estrogen screen cell assay [5] [6] [7] . Recent findings indicate that BPA, a weak estrogenic ED, activated the transcription factor, cAMP-responsive element binding protein (CREB), and phosphorylated CREB was increased in a calcium-dependent manner, suggesting a lowdose of BPA activates the transcription factor CREB via an alternative mechanism involved in a nonclassical membrane ER [8] . In addition, cell-based endogenous genes have been suggested as useful biomarkers including pS2, mucin 1 (MUC1), glucose-6-phosphate dehydrogenase, ornithine decarboxylase, ERs, AR, progesterone receptor (PR), clusterin, complement C3, lactoferrin, vitellogenin and cathepsin B [9, 10] . However, the expression level of these biomarkers is too low to be detected.
A few in vivo models are available, most of which are derived from the use of fish, amphibians and reptiles. Mammalian models are very few based on experimental findings, thus, in this review we summarize the novel biomarkers and screening methods for EDs in mammals in order to describe the usefulness of the indicated biomarkers.
Rat Models
Genistein is a plant-derived estrogenic isoflavone found in soy-based products. Treatment with genistein resulted in a significant increase in the vasopressin level which may have been associated with fluid balance, and altered blood pressure and cardiovascular effects, whereas no significant difference by dietary genistein was observed in the β-endorphin level of the rat hypothalamus [11] . These results may explain previous findings that estrogenic EDs such as genistein increase sodium preference in the hypothalamus of rats. In adult male Wistar rats administered BPA, the mRNA and protein levels of uridine diphosphate (UDP)-glucuronosyltransferase (UGT) activity were significantly decreased in liver microsomes, whereas the suppression of mRNA and protein UGT2B1 expression was not observed in female rats. This indicates that BPA treatment causes reduction of UGT2B1 and other UGT isoforms mediating the glucuronidation of sex hormones in adult male rats, and suggests that the endocrine balance may be disrupted by the suppression of glucuronidation [12] . The efficacy of screening metho ds for t he d et ec tion o f EDs has been compared among the receptor binding assay, reporter gene assay, and immature rat uterotrophic assay. Based on the results, the reporter gene or uterotrophic assay needs to be performed in the early stage of the screening process for EDs, because these methods can detect an antagonist activity caused by both inhibition of receptorligand interaction and transcriptional interference, which could be used for the high throughput screening process [13] .
Recently we have employed immature rats to detect an estrogenic compound, and demonstrated that the mRNA and protein levels of Calbindin-D9k (CaBP-9k) could be a novel biomarker for this model [14, 15] . CaBP-9k, a 9 kilodalton cytosolic calcium-binding protein, belongs to a family of intracellular proteins, which have high affinities for calcium, and has two calcium binding domains [16, 17] . It has been postulated that uterine CaBP-9k may be involved in controlling myometrial activity related to intracellular calcium levels [18] . The hormonal mechanism controlling the uterine CaBP9k gene is relatively well understood in the rat; for instance, estrogen is known to up-regulate, and progesterone to down-regulate the expression of the CaBP-9k gene in the rat uterus during the estrous cycle and early pregnancy [19] [20] [21] [22] . The C a B P -9 k m R N A e x p r e ss i o n o f e st r o g e n i c compounds in a dose-and time-dependent manner has been assessed by Dot and Northern blot analyses. Using dot blot analysis, a significant increase in CaBP-9k mRN A express ion was observed when the rats were treated with 1,000 mg/kg body weight/day of OP, NP and BPA for 3 days (Fig. 2) . As expected, a single dose of E2 treatment (40 mg/kg/day) for 3 days induced a significant increase CaPB-9k expression. However, treatment with 10 and 100 mg/kg/day of OP, NP and BPA for 3 days did not increase CaBP-9k mRNA expression. Using Northern blot analysis, a m or e d ramatic in crease of CaBP-9k mR N A expression was observed when 1,000 mg/kg/day of OP and NP was administered for 3 days. As seen in Fig. 3 , treatment with 10 and 100 mg/kg/day of NP and 100 mg/kg/day of OP for 3 days induced a small but significant increase in CaBP-9k mRNA expression. Treatment with 1000 mg/kg/day of BPA for 3 days induced a small increase, whereas 10 and 100 mg/kg/day of BPA did not increase CaBP-9k mRNA expression. As expected, a single dose of E2 (40 mg/kg/day) for 3 days induced a dramatic increase in CaBP-9k mRNA expression. In a time-dependent experiment, a significant increase in CaBP-9k mRN A express ion was observed by the treatments with OP, NP and BPA when measured by Dot and Northern blot analyses [15] . In addition, the expression level of ERα mRNA in uteri after treatment with OP, NP and BPA in a dose-dependent manner indicated a similar pattern to that of CaBP-9k mRNA. As shown in Fig. 4 , NP and OP (10, 100 or 1,000 mg/ k g/ d ay ) i nd u c ed i n c re as e s i n E Rα m R N A expression with maximum effect at 1,000 mg/kg/ day. Treatment with 1,000 mg/kg/day of BPA also induced a significant increase in ERα mRNA expression. In conclusion, the alkylphenolic compounds as well as E2 resulted in stimulation of the mRNA expressions of ERα and CaBP-9k, suggesting that CaBP-9k gene can be used as a biomarker gene for assaying estrogenicity of putative estrogenic compounds. In addition to the mRNA level of CaBP-9k, the effects of these estrogenic compounds on the ex pressio n of CaB P-9 k pr ot ein a nd uterine localization were examined in our previous study [14] . First of all, induction of uterine CaBP-9k protein by the estrogenic compounds was assessed in a dose-dependent manner by Western blot analysis. As seen in Fig. 5 , a dose-dependent increase in the CaBP-9k protein was observed in the rat uterus when treated with OP and NP for 3 days. It is of interest that BPA resulted in a significant increase in the CaBP-9k protein at a dose of 500 mg/kg/day. The localization of CaBP-9k protein after treatment with estrogenic compounds in a dose-dependent manner was further investigated. As seen in Fig. 6 , all of the estrogenic compounds and E2 induced the localization of CaBP-9k protein in the uterus of immature rats. The CaPB-9k protein was expressed mainly in the myometrium and partially in endometrial stroma of immature rats in response to treatment with estrogenic compounds. In addition, the CaBP-9k protein was expressed in the glandular epithelium of the endometrium, but was only expressed in a limited number of cells in the uterine epithelium (Fig. 6) . Treatment with the estrogenic compounds rarely induced the shift of the localization of CaPB-9k pro tein in t he ut er us of imm at ure rat s. In conclusion, we demonstrated that CaBP-9k protein is strongly up-regulated by estrogenic compounds (OP, NP and BPA) and E2 itself in the uterus of immature rats. These results indicate that CaBP-9k protein can be a useful biomarker for the detection o f t he es tr og enic ity of pu tat ive es t ro geni c compounds from 24 h after 3-day injection. Taken together, regarding risk assessment, we propose that both CaBP-9k mRNA and protein assays in the immature rat uterus are a very sensitive and powerful tools for identifying compounds with estrogenic activity.
Mouse Models
Uterine bioassays using immature CD-1 mice have been demonstrated to detect the effect of dietary factors in natural ingredient and purified diets. It is generally acknowledged that (1) total metabolizable energy in natural ingredients or purified diets has a significant effect on the uterine w e i g h ts o f i m m at u r e m i c e u se d i n 7-d a y uterotro phic bioas sa ys ; (2) a sta ndard iz ed , es tr og en-free d iet w it h a co ns t ant level o f m et abo lizable energy needs t o be used for conducting uterotrophic assays when comparing results between different laboratories or when determining the estrogenic or anti-estrogenic activity of EDs; (3) the mouse uterotrophic assay is a sensitive bioassay for assessing chemicals for estrogenic activity or for the detection of total estrogenic activity in rodent diets that may be contaminated with estrogenic compounds; and (4) chemical assays need to be used to detect or measure low levels of phytoestrogens in rodent diets [23] . The effect of OP has been investigated and compared with that of DES in ability to induce ERα expression in the newborn mouse uterine epithelium after prenatal exposure [24] . Exposure to DES induced the expression of both ERα mRNA and protein in the epithelium, whereas it was unchanged in the stroma. In contrast, OP did not induce the expression of ERα mRNA or protein in the epithelium and the expression was unchanged in the stroma, suggesting the importance of in vivo studies in the detection of EDs [24] . I n t h e m ale m o us e, s elec t ed m o no c lo n al antibodies against intra-acrosomal mammalian sp e r m pr ote i ns c r oss -r e ac ted w i th m o u se spermatozoa, which were analyzed for acrosome integrity to detect EDs [25] . In this study, BPA had a negative effect on in vivo fertility of mice, with impact on spermatogenesis and sperm quality, and the monoclonal antibodies could be used for detecting sperm damage due to EDs.
Hamster and Pig Models
Newborn hamsters were used and treated with either DES or E2 [26] . Neonatal DES exposure c a u se d g r e a te r m or p h ol o g i c a l d i sr u pt i on throughout the female reproductive tract in prepubertal and mature hamsters. In the uterus, a characteristic histopathological profile, including enhancement of both hyperplastic and apoptotic ac t i v i t y , w a s i n i t i a t ed pr e pu b e r t a l l y a n d exclusively in the endometrial epithelial cell co m par tm ent fro m n eona t a lly DES -t reated hamsters and then was promoted by E2 stimulation during adulthood. Interestingly, apoptotic activity was not detect ed in a n area o f endometria l epithelium that progressed to the neoplastic state in a DES-exposed animal. Lastly, chronic estrogen induction of lactoferrin was also restricted to the DES-exposed endometrium. It was concluded that DES is more potent than E2 as a perinatal endocrine disruptor in the hamster model, and that this hamster model is useful as a method for screening E D s f o r s u c h a c t i v i t y , t h e n t r a c i n g t h e i r mechanisms [26] . The use of the hamster model was widely reviewed in a recent article, which describes some unique advantages of the hamster for perinatal ED studies, the morphological and m olecular consequences of expo sure to the established perinatal ED, DES, in the female and male hamster, histomorphological insight into the process of neonatal DES-induced disruption in the hamster uterus, and recent efforts and future plans to evaluate the potency and mechanism of action of other putative EDs in the hamster model. In this review, the hamster model represents a unique and sensitive in vivo system to probe the phenomenon of endocrine disruption [27] . Male fetal domestic swine and mini-swine were us ed t o s t ud y t he effec t o f d io x in o n fet a l development and expression of ERα and epidermal growth factor receptor (EGFR). Genital anomalies were observed in 8 of 15 dioxin group animals and mean germ cell number was decreased in the dioxin group animals [28] . ERα protein level was increased 2-to 3-fold in dioxin exposed testes, and the m RN A level was significant ly low er in gubernaculums and epididymis, whereas no difference was observed in the expression level of EGFR mRNA, suggesting that aberrant regulation of ERα expression by dioxin may contribute to reproductive tract anomalies in male fetuses [28] .
Humans
D ir ect assays of BP A, a w eak estr og enic compound in the manufacture of a wide range of consumer products, in human blood [29, 30] and cadmium in the induction of steroidogenesis in rat and human placental tissues [31] have been performed to detect estrogenic EDs. A high concentration of serum BPA was observed in normal men and in women with polycystic ovary syndrome compared with normal women [30] . In addition, significant positive correlations between se r u m B P A an d t ota l t es tos ter on e o r fr e e testosterone concentration in all subjects were found in this study, suggesting that there may be gender differences in serum BPA concentrations, possibly due to differences in the androgen-related metabolism of BPA [30] .
Concluding Remarks
Recent investigations demonstrate that our environment is contaminated with many EDs, which can interfere with the endocrine systems and adversely effect hormone balance or disrupt normal function, eventually leading to detrimental effects in the reproductive and developmental processes. Despites the existence of these hormonal EDs, there are no standard methods to measure their risk. The in vitro methods for detection of estrogenic compounds have been developed using estrogen-dependent cell lines such as the MCF-7 breast cancer cell line. Many biomarkers in in vitro models were suggested for the detection of estrogenic compounds including pS2, MUC1 and steroid hormone receptors (ER, AR and PR) etc., even though their expression levels are too low to be detected. Recently, it has been reported that the es trogenic compound, BPA, may a lter gene expression via a new pathway involving CREB activation after binding to non classical membrane E R s , in d ic a t i n g a n ew m ec h a n i s m f o r t h e differences found in the estrogenicity of EDs [8] . Furt her st udies are n eed ed t o u nco v er t he mechanisms of EDs in the signaling pathways in order to recognize the distinct mechanisms of cellular signaling by endogenous steroid hormones and EDs
Most methods are derived from assays that measure estrogenic activity, these fewer data are available from assays that measure androgenic and progestogenic activities. Not only estrogenic EDs but also androgenic or progestogenic EDs may i n te r f e r e w i t h h u m a n h e a l t h d u r i n g th e reproductive and developmental process. For example, androgenic EDs may affect fertility and reproduction in men, and progestogenic EDs derived from maternal blood through placenta may affect development of the fetus during pregnancy. Thus more reliable in vitro and in vivo biomarkers a r e n ec es s a ry fo r de t ec t in g a nd r o g eni c o r progestogenic EDs detrimental to human health.
